back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-07-14 19:18 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+75,484 vol |
75,484 | |
| Filed 2023-07-14 19:17 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-452,900 vol |
0 | |
| Filed 2022-06-23 15:53 Tx date 2022-06-22 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+165,000 vol |
452,900 | |
| Filed 2021-11-15 14:31 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+287,900 vol |
287,900 | |
| Filed 2021-11-15 14:30 Tx date 2020-09-14 |
$ACST
Acasti Pharma Inc. |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-15 Tx date 2015-12-31 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Holder: Sunlife Canada (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,648
+13,753 vol $0.338 each |
33,057 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$105,000
+250,000 vol $0.42 each |
||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$103,750
+250,000 vol $0.415 each |
510,000 |